Zhu W, London NR, Gibson CC, Davis CT, Tong Z, Sorensen LK, Shi DS, Guo J, Smith MC, Grossmann AH, Thomas KR, Li DY

The innate immune response is essential for combating infectious disease. Macrophages and other cells respond to infection by releasing cytokines, such as interleukin-1? (IL-1?), which in turn activate a well-described, myeloid-differentiation factor 88 (MYD88)-mediated, nuclear factor-?B (NF-?B)-dependent transcriptional pathway that results in inflammatory-cell activation and recruitment. Endothelial cells, which usually ...

Read More

serve as a barrier to the movement of inflammatory cells out of the blood and into tissue, are also critical mediators of the inflammatory response. Paradoxically, the cytokines vital to a successful immune defence also have disruptive effects on endothelial cell-cell interactions and can trigger degradation of barrier function and dissociation of tissue architecture. The mechanism of this barrier dissolution and its relationship to the canonical NF-?B pathway remain poorly defined. Here we show that the direct, immediate and disruptive effects of IL-1? on endothelial stability in a human in vitro cell model are NF-?B independent and are instead the result of signalling through the small GTPase ADP-ribosylation factor 6 (ARF6) and its activator ARF nucleotide binding site opener (ARNO; also known as CYTH2). Moreover, we show that ARNO binds directly to the adaptor protein MYD88, and thus propose MYD88-ARNO-ARF6 as a proximal IL-1? signalling pathway distinct from that mediated by NF-?B. Finally, we show that SecinH3, an inhibitor of ARF guanine nucleotide-exchange factors such as ARNO, enhances vascular stability and significantly improves outcomes in animal models of inflammatory arthritis and acute inflammation.

Date: Dec. 13, 2012

View in: Pubmed Google Scholar

221494